About This EventHemab Therapeutics (Nasdaq: COAG), a clinical-stage biotechnology company developing therapies that reimagine ...
Key data is currently not available. Data Disclaimer: The Nasdaq Indices and the Major Indices are delayed at least 1 minute.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results